Skip to content
Search

Latest Stories

Ethnic health inequality review calls for radical action; RPS supports demand

A review into ethnic inequalities in healthcare, commissioned by NHS Race and Health Observatory, has called for a radical action on stark ethnic inequalities across the healthcare system.

The report, published on Monday (February 14), revealed vast inequalities across a range of health services, noting that mental healthcare treatment being poorest for the people of colour.


It called for ‘critical action’ to be undertaken by organisations including NHS England, NHS Improvement and NHS Digital, with recommendations outlined by the report.

The university-led review explores various areas related to access, experiences, and outcomes in services such as mental healthcare, maternal and neonatal healthcare, digital access to healthcare, genetic testing and genomic medicine, and the NHS workforce.

It stated: “Ethnic inequalities were found across each area studied. Whilst there were differences between ethnic minority groups, some communities were found to have particularly poor access, experiences and outcomes.”

With respect to the NHS workforce, it also analysed the impact of racism on careers and professional development and found “evidence of an ethnic pay gap affecting Black, Asian, Mixed and Other groups, and to a lesser extent, Chinese staff.”

Dr Habib Naqvi, director of the NHS Race and Health Observatory, said: “It is clear that existing evidence on the stark health inequalities faced by ethnic minority communities has not led to significant change. This is why the Observatory has been established: to synthesise what already exists, translate it into actionable policy recommendations, and to challenge leaders to act.

“This report should be a tool for them; highlighting the best quality evidence and making concrete recommendations for change.

With the report “we have made a clear and overwhelming case for radical action on race inequity in our healthcare system.”

Commenting on the report, Royal Pharmaceutical Society director for England Ravi Sharma said: “This evidence in this report is truly shocking. It’s totally unacceptable that ethnic minorities continue to experience poor access and outcomes across a wide range of health conditions, and that the NHS workforce is disadvantaged.

“Recommendations such as improving ethnicity data collection, examining ethnic pay gaps, and reviewing recruitment and staff development procedures, will enable a greater understanding of the barriers still to be removed for staff to progress within the NHS.

“Ultimately we want to see more ethnic minority colleagues in leadership positions locally, regionally and nationally. Without this, our perspective is bypassed, our skills and contributions are missed and inequalities are perpetuated for patients and the workforce."

With 45 per cent of the workforce in the pharmacy profession comprising Black, Asian and Minority Ethnic colleagues, Sharma called for inclusion of pharmacy in national plans to improve inclusive pharmacy practice.

The move will not only benefit patients and ensure representation of the workforce at all levels but also “protect the safety and wellbeing of pharmacists, their teams and the communities they serve.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less